The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
Synopsis
Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
The global Small Molecule Targeted Drugs for Allergic Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule Targeted Drugs for Allergic Diseases in Atopic Dermatitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule Targeted Drugs for Allergic Diseases include AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, AstraZeneca, Incyte, Jiangsu Hengrui Pharmaceuticals and Suzhou Zelgen Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Drugs for Allergic Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Drugs for Allergic Diseases.
Report Scope
The Small Molecule Targeted Drugs for Allergic Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Targeted Drugs for Allergic Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Drugs for Allergic Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Pfizer
Novartis
Eli Lilly and Company
LEO Pharma
AstraZeneca
Incyte
Jiangsu Hengrui Pharmaceuticals
Suzhou Zelgen Biopharmaceuticals
Segment by Type
JAK
TYK2
Segment by Application
Atopic Dermatitis
Asthma
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Drugs for Allergic Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
The global Small Molecule Targeted Drugs for Allergic Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule Targeted Drugs for Allergic Diseases in Atopic Dermatitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule Targeted Drugs for Allergic Diseases include AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, AstraZeneca, Incyte, Jiangsu Hengrui Pharmaceuticals and Suzhou Zelgen Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Drugs for Allergic Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Drugs for Allergic Diseases.
Report Scope
The Small Molecule Targeted Drugs for Allergic Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Targeted Drugs for Allergic Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Drugs for Allergic Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Pfizer
Novartis
Eli Lilly and Company
LEO Pharma
AstraZeneca
Incyte
Jiangsu Hengrui Pharmaceuticals
Suzhou Zelgen Biopharmaceuticals
Segment by Type
JAK
TYK2
Segment by Application
Atopic Dermatitis
Asthma
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Drugs for Allergic Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 JAK
1.2.3 TYK2
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Atopic Dermatitis
1.3.3 Asthma
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Perspective (2019-2030)
2.2 Small Molecule Targeted Drugs for Allergic Diseases Growth Trends by Region
2.2.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule Targeted Drugs for Allergic Diseases Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule Targeted Drugs for Allergic Diseases Market Dynamics
2.3.1 Small Molecule Targeted Drugs for Allergic Diseases Industry Trends
2.3.2 Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
2.3.3 Small Molecule Targeted Drugs for Allergic Diseases Market Challenges
2.3.4 Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Revenue
3.1.1 Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Revenue (2019-2024)
3.1.2 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Drugs for Allergic Diseases Revenue
3.4 Global Small Molecule Targeted Drugs for Allergic Diseases Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Drugs for Allergic Diseases Revenue in 2023
3.5 Small Molecule Targeted Drugs for Allergic Diseases Key Players Head office and Area Served
3.6 Key Players Small Molecule Targeted Drugs for Allergic Diseases Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Drugs for Allergic Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Drugs for Allergic Diseases Breakdown Data by Type
4.1 Global Small Molecule Targeted Drugs for Allergic Diseases Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2025-2030)
5 Small Molecule Targeted Drugs for Allergic Diseases Breakdown Data by Application
5.1 Global Small Molecule Targeted Drugs for Allergic Diseases Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size (2019-2030)
6.2 North America Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
6.4 North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size (2019-2030)
7.2 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
7.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size (2019-2030)
8.2 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size (2019-2030)
9.2 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
9.4 Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size (2019-2030)
10.2 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.1.4 AbbVie Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.2.4 Pfizer Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.3.4 Novartis Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Detail
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.4.4 Eli Lilly and Company Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.4.5 Eli Lilly and Company Recent Development
11.5 LEO Pharma
11.5.1 LEO Pharma Company Detail
11.5.2 LEO Pharma Business Overview
11.5.3 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.5.4 LEO Pharma Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.5.5 LEO Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.6.4 AstraZeneca Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Incyte
11.7.1 Incyte Company Detail
11.7.2 Incyte Business Overview
11.7.3 Incyte Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.7.4 Incyte Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.7.5 Incyte Recent Development
11.8 Jiangsu Hengrui Pharmaceuticals
11.8.1 Jiangsu Hengrui Pharmaceuticals Company Detail
11.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.8.3 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.8.4 Jiangsu Hengrui Pharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.8.5 Jiangsu Hengrui Pharmaceuticals Recent Development
11.9 Suzhou Zelgen Biopharmaceuticals
11.9.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.9.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.9.3 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Introduction
11.9.4 Suzhou Zelgen Biopharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
11.9.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of JAK
Table 3. Key Players of TYK2
Table 4. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region (2019-2024)
Table 8. Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region (2025-2030)
Table 10. Small Molecule Targeted Drugs for Allergic Diseases Market Trends
Table 11. Small Molecule Targeted Drugs for Allergic Diseases Market Drivers
Table 12. Small Molecule Targeted Drugs for Allergic Diseases Market Challenges
Table 13. Small Molecule Targeted Drugs for Allergic Diseases Market Restraints
Table 14. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Players (2019-2024)
Table 16. Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Drugs for Allergic Diseases as of 2023)
Table 17. Ranking of Global Top Small Molecule Targeted Drugs for Allergic Diseases Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Small Molecule Targeted Drugs for Allergic Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Small Molecule Targeted Drugs for Allergic Diseases Product Solution and Service
Table 21. Date of Enter into Small Molecule Targeted Drugs for Allergic Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2019-2024)
Table 25. Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2025-2030)
Table 27. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2019-2024)
Table 29. Global Small Molecule Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2025-2030)
Table 31. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product
Table 49. AbbVie Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product
Table 54. Pfizer Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Small Molecule Targeted Drugs for Allergic Diseases Product
Table 59. Novartis Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Eli Lilly and Company Company Detail
Table 62. Eli Lilly and Company Business Overview
Table 63. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product
Table 64. Eli Lilly and Company Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 65. Eli Lilly and Company Recent Development
Table 66. LEO Pharma Company Detail
Table 67. LEO Pharma Business Overview
Table 68. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product
Table 69. LEO Pharma Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 70. LEO Pharma Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product
Table 74. AstraZeneca Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Incyte Company Detail
Table 77. Incyte Business Overview
Table 78. Incyte Small Molecule Targeted Drugs for Allergic Diseases Product
Table 79. Incyte Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 80. Incyte Recent Development
Table 81. Jiangsu Hengrui Pharmaceuticals Company Detail
Table 82. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 83. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product
Table 84. Jiangsu Hengrui Pharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 85. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 86. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 87. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 88. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product
Table 89. Suzhou Zelgen Biopharmaceuticals Revenue in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
Table 90. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Type: 2023 VS 2030
Figure 3. JAK Features
Figure 4. TYK2 Features
Figure 5. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Application: 2023 VS 2030
Figure 7. Atopic Dermatitis Case Studies
Figure 8. Asthma Case Studies
Figure 9. Others Case Studies
Figure 10. Small Molecule Targeted Drugs for Allergic Diseases Report Years Considered
Figure 11. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region: 2023 VS 2030
Figure 14. Global Small Molecule Targeted Drugs for Allergic Diseases Market Share by Players in 2023
Figure 15. Global Top Small Molecule Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Drugs for Allergic Diseases as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Small Molecule Targeted Drugs for Allergic Diseases Revenue in 2023
Figure 17. North America Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
Figure 19. United States Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
Figure 23. Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Targeted Drugs for Allergic Diseases Market Share by Region (2019-2030)
Figure 31. China Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
Figure 39. Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
Figure 43. Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Small Molecule Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. AbbVie Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 46. Pfizer Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 48. Eli Lilly and Company Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 49. LEO Pharma Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 51. Incyte Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 52. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 53. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Small Molecule Targeted Drugs for Allergic Diseases Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
